SearchDictionaryMobileLogin

Thomas Müller Selected Research

Parkinson Disease (Parkinson's Disease)

08/2008A comprehensive genetic study of the proteasomal subunit S6 ATPase in German Parkinson's disease patients.
07/2008Entacapone improves absorption of a coadministered salt in patients with Parkinson's disease.
06/2008Role of homocysteine in the treatment of Parkinson"s disease.
06/2008Impact of endurance exercise on levodopa-associated cortisol release and force increase in patients with Parkinson's disease.
05/2008Catechol-O-methyltransferase inhibition improves levodopa-associated strength increase in patients with Parkinson disease.
12/2007Relating mode of action to clinical practice: Dopaminergic agents in Parkinson's disease.
07/2007Endurance exercise modulates levodopa induced growth hormone release in patients with Parkinson's disease.
07/2007Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.
05/2007Entacapone improves complex movement performance in patients with Parkinson's disease.
03/2007Acute levodopa intake and associated cortisol decrease in patients with Parkinson disease.
02/2007Exercise improves efficacy of levodopa in patients with Parkinson's disease.
01/2007Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial.
09/2006Levodopa availability improves with progression of Parkinson's disease.
09/2006Levodopa, motor fluctuations and dyskinesia in Parkinson's disease.
06/2006Tolcapone decreases plasma levels of S-adenosyl-L-homocysteine and homocysteine in treated Parkinson's disease patients.
03/2006Impact of gastric emptying on levodopa pharmacokinetics in Parkinson disease patients.
11/2005Levodopa intake increases plasma levels of S-adenosylmethionine in treated patients with Parkinson disease.
09/2005Impact of levodopa on reduced nerve growth factor levels in patients with Parkinson disease.
09/2005Alpha-synuclein and Parkinson's disease: implications from the screening of more than 1,900 patients.
06/2004Chronic levodopa intake increases levodopa plasma bioavailability in patients with Parkinson's disease.
05/2003Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease.
05/2003Fibrosis associated with dopamine agonist therapy in Parkinson's disease.
03/2003Intravenous amantadine sulphate application improves the performance of complex but not simple motor tasks in patients with Parkinson's disease.
06/2002Polymorphisms in the interleukin-1 alpha and beta genes and the risk for Parkinson's disease.
05/2002Budipine provides additional benefit in patients with Parkinson disease receiving a stable optimum dopaminergic drug regimen.

Articles by Research Topic

Disease

25Parkinson Disease (Parkinson's Disease)
08/2008 - 05/2002
3Dyskinesias (Dyskinesia)
01/2007 - 09/2002
2Huntington Disease (Huntington's Disease)
01/2005 - 02/2004
2Multiple Sclerosis
11/2004 - 07/2003
1Diarrhea
09/2008
1Neuroblastoma
05/2008
1Small Cell Carcinoma
08/2007
1Hepatolenticular Degeneration (Wilson's Disease)
08/2007
1Asthma (Bronchial Asthma)
08/2007
1Inflammation
10/2006
1Chronic Progressive Multiple Sclerosis
09/2006
1Relapsing-Remitting Multiple Sclerosis
01/2006
1Paresthesia (Dysesthesia)
01/2006
1Reperfusion Injury
10/2005
1Glycogen Storage Disease (Glycogenosis)
11/2004
1Pancreatitis
09/2004
1Fibrosis (Cirrhosis)
05/2003
1Syndrome
12/2002
1Chronic Kidney Failure (Chronic Renal Failure)
11/2002
1Meningomyelocele (Myelomeningocele)
11/2002
1Neoplasms (Cancer)
10/2002
1Stroke (Strokes)
09/2002

Drug/Important Bio-Agent (IBA)

11Levodopa (L Dopa)FDA LinkGeneric
06/2008 - 06/2004
4Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
09/2006 - 07/2003
3HomocysteineIBA
06/2008 - 02/2004
2entacapone (Comtan)FDA Link
07/2008 - 05/2007
2Hydrocortisone (Cortisol)FDA LinkGeneric
06/2008 - 03/2007
1Nonsense Codon (Nonsense Mutation)IBA
09/2008
1Adenosine Triphosphatases (ATPase)IBA
08/2008
1Cisplatin (Platino)FDA LinkGeneric
05/2008
1Selegiline (E250)FDA LinkGeneric
05/2008
1Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
05/2008
1Dopamine Agents (Dopaminergic Agents)IBA
12/2007
1Penicillamine (Cuprimine)FDA Link
08/2007
1irinotecan (Camptosar)FDA LinkGeneric
08/2007
1Carboplatin (JM8)FDA LinkGeneric
08/2007
1ciclesonideFDA Link
08/2007
1fluticasone (Cutivate)FDA LinkGeneric
08/2007
1Growth Hormone (Somatotropin)IBA
07/2007
1UbiquinoneIBA
07/2007
1sarizotanIBA
01/2007
1SmokeIBA
10/2006
1Mitoxantrone (Novantrone)FDA LinkGeneric
09/2006
1tolcapone (Tasmar)FDA Link
06/2006
1S-Adenosylmethionine (Ademetionine)IBA
11/2005
1Epoprostenol (Prostacyclin)FDA LinkGeneric
10/2005
1Iloprost (Ventavis)FDA Link
10/2005
1alpha-SynucleinIBA
09/2005
1Nerve Growth Factor (NGF)IBA
09/2005
1OxidoreductasesIBA
01/2005
11,4-alpha-Glucan Branching Enzyme (Glycogen Branching Enzyme)IBA
11/2004
1coenzyme Q10 (CoQ10)IBA
05/2003
1Dopamine Agonists (Dopamine Agonist)IBA
05/2003
1Amantadine (Aman)FDA LinkGeneric
03/2003
1Pergolide (Permax)FDA Link
12/2002
1Bromocriptine (Parlodel)FDA LinkGeneric
12/2002
1beta CateninIBA
10/2002
1quetiapine (Seroquel)FDA Link
09/2002
1Interleukin-1alpha (Interleukin 1 alpha)IBA
06/2002
1budipineIBA
05/2002

Therapy/Procedure

1Enteral Nutrition (Feeding, Tube)
09/2004
1Jejunostomy
09/2004
1Renal Replacement Therapy (Therapies, Renal Replacement)
11/2002
1Transplantation (Transplant Recipients)
11/2002